TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Urologix AB
Closing information (x1000 NOK)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
6,780
|
7,010 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
1,650
|
1,852 | |
EBITDA |
1,778
|
1,887 | |
Total assets |
2,052
|
2,198 | |
Current assets |
1,197
|
1,997 | |
Current liabilities |
504
|
529 | |
Equity capital |
1,548
|
1,669 | |
- share capital |
98
|
92 | |
Employees (average) |
4
|
5
![]() |
5 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
75.4%
|
75.9% | |
Turnover per employee |
1,356
|
1,402 | |
Profit as a percentage of turnover |
24.3%
|
26.4% | |
Return on assets (ROA) |
80.4%
|
84.3% | |
Current ratio |
237.5%
|
377.5% | |
Return on equity (ROE) |
106.6%
|
111.0% | |
Change turnover |
-652
|
473 | |
Change turnover % |
0%
|
-9%
|
7% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-20%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.